Research Portal

Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland

Research output: Contribution to journal › Article › peer-review

Standard Standard

Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland. / Ciblis, A.S.; Butler, M.L.; Bokde, L.W. et al.
In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 1, No. 1, 29.03.2015, p. 41-47.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Ciblis, AS, Butler, ML, Bokde, LW, Mullins, PG, O'Neill, D & McNulty, JP 2015, 'Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 1, no. 1, pp. 41-47. https://doi.org/10.1016/j.dadm.2014.11.011

APA

Ciblis, A. S., Butler, M. L., Bokde, L. W., Mullins, P. G., O'Neill, D., & McNulty, J. P. (2015). Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 1(1), 41-47. https://doi.org/10.1016/j.dadm.2014.11.011

CBE

Ciblis AS, Butler ML, Bokde LW, Mullins PG, O'Neill D, McNulty JP. 2015. Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 1(1):41-47. https://doi.org/10.1016/j.dadm.2014.11.011

MLA

Ciblis, A.S. et al. "Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland". Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2015, 1(1). 41-47. https://doi.org/10.1016/j.dadm.2014.11.011

VancouverVancouver

Ciblis AS, Butler ML, Bokde LW, Mullins PG, O'Neill D, McNulty JP. Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2015 Mar 29;1(1):41-47. doi: 10.1016/j.dadm.2014.11.011

Author

Ciblis, A.S. ; Butler, M.L. ; Bokde, L.W. et al. / Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland. In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2015 ; Vol. 1, No. 1. pp. 41-47.

RIS

TY - JOUR

T1 - Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland

AU - Ciblis, A.S.

AU - Butler, M.L.

AU - Bokde, L.W.

AU - Mullins, P.G.

AU - O'Neill, D.

AU - McNulty, J.P.

PY - 2015/3/29

Y1 - 2015/3/29

N2 - Background: Neuroimaging is an increasingly important tool in the diagnostic workup of dementia. Neurologists, geriatricians, and old-age psychiatrists are involved in key tasks in the diagnostic process, frequently referring patients with suspected dementia for neuroimaging. Methods: The research design was a postal survey of all geriatricians, old-age psychiatrists, and neurologists in the Republic of Ireland (N5176) as identified by the Irish Medical Directory 2011–2012 and supplementary listings. Results: Almost 65% of specialists did not have access to 2-[18F]fluoro-2-deoxy-D-glucose positron emission (FDG-PET) or FDG-PET/computed tomography (CT), and 80.3% did not have access to perfusion hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) or dopaminergic iodine-123-radiolabeled 2b-carbomethoxy-3b-(4-iodophenyl)-N- (3-fluoropropyl) nortropane SPECT. Most specialists (88.7%) referred patients with mild cognitive impairment or suspected dementia for magnetic resonance imaging (MRI), 81.7% referred for CT, and 26.8% for FDG-PET or FDG-PET/CT. Only 44.6% of respondents were aware of dementiaspecific protocols for referrals for neuroimaging. Conclusion: Specialist access to imaging modalities other than CT and MRI is restricted. Improved access may affect patient treatment and care..

AB - Background: Neuroimaging is an increasingly important tool in the diagnostic workup of dementia. Neurologists, geriatricians, and old-age psychiatrists are involved in key tasks in the diagnostic process, frequently referring patients with suspected dementia for neuroimaging. Methods: The research design was a postal survey of all geriatricians, old-age psychiatrists, and neurologists in the Republic of Ireland (N5176) as identified by the Irish Medical Directory 2011–2012 and supplementary listings. Results: Almost 65% of specialists did not have access to 2-[18F]fluoro-2-deoxy-D-glucose positron emission (FDG-PET) or FDG-PET/computed tomography (CT), and 80.3% did not have access to perfusion hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) or dopaminergic iodine-123-radiolabeled 2b-carbomethoxy-3b-(4-iodophenyl)-N- (3-fluoropropyl) nortropane SPECT. Most specialists (88.7%) referred patients with mild cognitive impairment or suspected dementia for magnetic resonance imaging (MRI), 81.7% referred for CT, and 26.8% for FDG-PET or FDG-PET/CT. Only 44.6% of respondents were aware of dementiaspecific protocols for referrals for neuroimaging. Conclusion: Specialist access to imaging modalities other than CT and MRI is restricted. Improved access may affect patient treatment and care..

U2 - 10.1016/j.dadm.2014.11.011

DO - 10.1016/j.dadm.2014.11.011

M3 - Article

VL - 1

SP - 41

EP - 47

JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

SN - 2352-8729

IS - 1

ER -